FDA Inspection 675339 — National Human Genome Therapy Research IRB
The FDA completed an inspection of National Human Genome Therapy Research IRB on Aug 9, 2010 in Bethesda, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 9, 2010
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Bethesda, MD (United States)
Additional Details
IRB